Skip to content

KeyScope Study in Uganda

KeyScope: First-In-Human Clinical Study for Cancer Diagnosis in Uganda

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06212570
Enrollment
12
Registered
2024-01-19
Start date
2026-09-01
Completion date
2028-06-30
Last updated
2026-08-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominal Neoplasm

Brief summary

KeyScope and KeyLoop (collectively called KeySuite) are laparoscopic prototypes that the investigators have designed for the resources, needs and challenges of low- and middle- income countries (LMICs). KeyScope is a laparoscope that plugs into a laptop computer to display images during surgery. It links to a telementoring application so that experienced surgeons can mentor surgeons in capacity-building partnerships. KeyLoop is a laparoscopic retractor that lifts the abdominal wall during surgery, obviating the need for a constant power supply and medical-grade carbon dioxide. The investigators will perform a clinical First-in-Human study at the Uganda Cancer Institute. Ugandan surgeons will use the KeySuite devices to perform biopsies of intra-abdominal tumors.

Interventions

DEVICEKeySuite

KeyScope and KeyLoop will be used to perform biopsies of intra-abdominal masses and cancers.

Sponsors

Duke University
Lead SponsorOTHER
Makerere University
CollaboratorOTHER
Uganda Cancer Institute
CollaboratorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* diagnosis of intra-abdominal mass suspicious for cancer * body mass index (BMI) of 18-30 * weight 20-100kg * biopsy necessary to determine cancer diagnosis and classify pathology * surgeon determine that laproscopic biopsy it technically appropriate

Exclusion criteria

* significant comorbidities * previous major abdominal surgery * current pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Establish the clinical safety KeySuiteDay of surgeryThis will be determined by whether or not the procedure was able to be completed laproscopically or had to be converted to open surgery.

Secondary

MeasureTime frameDescription
Time to complete surgeryDay of surgeryLength of surgery will be recorded
Estimated blood lossDay of surgeryBlood loss will be recorded
Surgical injuries and adverse eventsDay of surgerySurgical injuries (device-related and unrelated) and other adverse events at the time of surgery will be recorded

Countries

Uganda

Contacts

CONTACTTamara Fitzgerald, MD, PhD
tamara.fitzgerald@duke.edu919-681-5077
CONTACTDana Giangiacomo
dana.giangiacomo@duke.edu919-684-3821
PRINCIPAL_INVESTIGATORTamara Fitzgerald, MD, PhD

Duke Health

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 7, 2026